Area of research
Infectious Diseases · Statistics and Probability
Research interest
Research interests include Statistical Methods in Clinical Trials, Tuberculosis Research and Epidemiology, Infectious Diseases and Tuberculosis, and Health Systems, Economic Evaluations, Quality of Life.
Clinical testing of drug treatment shortening in patients with TB using PET/CT imaging of lung lesions.
Tecovirimat for Clade I MPXV Infection in the Democratic Republic of Congo.
Three Cases of Vertical Transmission of Clade Ib Mpox Virus
Three Cases of Vertical Transmission of Clade Ib Mpox Virus.
Group‐Sequential Designs With an Externally‐Driven Change of Primary Endpoint
Group-Sequential Designs With an Externally-Driven Change of Primary Endpoint.
CAnceR IN PreGnancy (CARING) – a retrospective study of cancer diagnosed during pregnancy in the United Kingdom
Group sequential designs for clinical trials when the maximum sample size is uncertain
Group sequential designs for clinical trials when the maximum sample size is uncertain.
Effects of remdesivir in patients hospitalised with COVID-19: a systematic review and individual patient data meta-analysis of randomised controlled trials
Counting Monkeypox Lesions in Patient Photographs: Limits of Agreement of Manual Counts and Artificial Intelligence.
Baricitinib versus dexamethasone for adults hospitalised with COVID-19 (ACTT-4): a randomised, double-blind, double placebo-controlled trial
Fourteen-day PET/CT imaging to monitor drug combination activity in treated individuals with tuberculosis.
How to Quantify and Interpret Treatment Effects in Comparative Clinical Studies of COVID-19.
Endpoints for randomized controlled clinical trials for COVID-19 treatments.
The importance of adherence in tuberculosis treatment clinical trials and its relevance in explanatory and pragmatic trials
A meta-analysis of clinical studies conducted during the West Africa Ebola virus disease outbreak confirms the need for randomized control groups
A meta-analysis of clinical studies conducted during the West Africa Ebola virus disease outbreak confirms the need for randomized control groups.
Using biomarkers to predict TB treatment duration (Predict TB): a prospective, randomized, noninferiority, treatment shortening clinical trial
Persisting positron emission tomography lesion activity and Mycobacterium tuberculosis mRNA after tuberculosis cure
Evaluation of Tuberculosis Diagnostics in Children: 2. Methodological Issues for Conducting and Reporting Research Evaluations of Tuberculosis Diagnostics for Intrathoracic Tuberculosis in Children. Consensus From an Expert Panela
Evaluating Imaging and Computer-aided Detection and Diagnosis Devices at the FDA